MICHAEL JOHN TOMSICEK Insider Trading for September 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL JOHN TOMSICEK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of MICHAEL JOHN TOMSICEK for September 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | M | 17.75 | 12,000 | 213,000 | 156,000 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 93.18 | 2,800 | 260,904 | 410 | 3.2 K to 410 (-87.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 92.23 | 6,400 | 590,272 | 3,210 | 9.6 K to 3.2 K (-66.60 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 91.39 | 2,800 | 255,892 | 9,610 | 12.4 K to 9.6 K (-22.56 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 17.75 | 12,000 | 213,000 | 12,410 | 410 to 12.4 K (+2,926.83 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | M | 17.75 | 12,000 | 213,000 | 156,000 | |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 93.18 | 2,800 | 260,904 | 410 | 3.2 K to 410 (-87.23 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 92.23 | 6,400 | 590,272 | 3,210 | 9.6 K to 3.2 K (-66.60 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 91.39 | 2,800 | 255,892 | 9,610 | 12.4 K to 9.6 K (-22.56 %) |
| Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 17.75 | 12,000 | 213,000 | 12,410 | 410 to 12.4 K (+2,926.83 %) |